<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Tunneled hemodialysis catheter-related bloodstream infection (CRBSI): Epidemiology, pathogenesis, clinical manifestations, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Tunneled hemodialysis catheter-related bloodstream infection (CRBSI): Epidemiology, pathogenesis, clinical manifestations, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Tunneled hemodialysis catheter-related bloodstream infection (CRBSI): Epidemiology, pathogenesis, clinical manifestations, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael Allon, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel J Sexton, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeffrey S Berns, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Eric N Taylor, MD, MSc, FASN
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 21, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1494691522">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the United States, approximately 80 percent of patients initiate hemodialysis with a tunneled, cuffed dual-lumen catheter, and approximately 20 percent of all prevalent hemodialysis patients use such catheters [
         <a href="#rid1">
          1,2
         </a>
         ]. Tunneled double-lumen catheters are generally used for short- and intermediate-term venous access in hemodialysis patients. These catheters are also used for permanent vascular access in some patients, particularly those with limited alternative options for vascular access [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1843.html" rel="external">
          "Central venous catheters for acute and chronic hemodialysis access and their management"
         </a>
         .)
        </p>
        <p>
         Tunneled catheters are associated with a number of complications and, in particular, hemodialysis catheter-related bloodstream infection (CRBSI). The epidemiology, pathogenesis, clinical manifestations, and diagnosis of CRBSI are presented in this topic review. Treatment and prevention of CRBSI are presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1966.html" rel="external">
          "Tunneled hemodialysis catheter-related bloodstream infection (CRBSI): Management and prevention"
         </a>
         .)
        </p>
        <p>
         Complications related to nontunneled catheters and noninfectious catheter-related complications, such as central vein stenosis and catheter thrombosis, are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1913.html" rel="external">
          "Central vein obstruction associated with upper extremity hemodialysis access"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1906.html" rel="external">
          "Malfunction of chronic hemodialysis catheters"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1843.html" rel="external">
          "Central venous catheters for acute and chronic hemodialysis access and their management", section on 'Introduction'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8180.html" rel="external">
          "Central venous catheters: Overview of complications and prevention in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8194.html" rel="external">
          "Central venous access in adults: General principles"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3672513994">
         <span class="h1">
          EPIDEMIOLOGY AND RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of bloodstream infections in patients on hemodialysis are caused by infection of vascular access catheters. Most infections are due to skin flora colonizing the site around the site of the catheter placement [
         <a href="#rid3">
          3
         </a>
         ]. The frequency of hemodialysis catheter-related bloodstream infections (CRBSIs) in several large case series has ranged between three and six episodes per 1000 catheter-days, which corresponds to an approximate incidence of one to two episodes of bacteremia per catheter-year [
         <a href="#rid4">
          4
         </a>
         ]. In one study of 472 patients who had newly placed tunneled hemodialysis catheters, CRBSIs occurred in 35 percent by three months and 54 percent by six months [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         CRBSIs among patients who have nontunneled catheters are two- to threefold more frequent compared with patients who have tunneled catheters, in part because of differences in catheter design [
         <a href="#rid6">
          6,7
         </a>
         ]. As an example, the cuff on the outside of tunneled catheters forms a mechanical barrier that limits entry of skin flora along the outer wall of the catheter. By contrast, nontunneled catheters have no cuff, thereby allowing introduction of bacteria both through the catheter lumen and along the outer wall of the catheter.
        </p>
        <p>
         The incidence of bacteremia is approximately 10-fold higher in patients with tunneled catheters compared with patients who have either arteriovenous (AV) fistulas or grafts [
         <a href="#rid8">
          8-10
         </a>
         ]. In addition, catheter-dependent hemodialysis patients have a two- to threefold higher risk of infection-related hospitalization and infection-related death compared with patients undergoing hemodialysis via an AV fistula or graft [
         <a href="#rid11">
          11,12
         </a>
         ].
        </p>
        <p>
         The clinical impact of catheter use in hemodialysis patients has been quantified in several studies [
         <a href="#rid8">
          8,13-15
         </a>
         ]. As an example, in the Hemodialysis (HEMO) study, 7.6 percent of all patients had catheters used for vascular access, yet this group comprised 32 percent of all study patients hospitalized with an access-related infection [
         <a href="#rid15">
          15
         </a>
         ]. In another prospective study of 2666 Scottish patients on kidney replacement therapy, use of a tunneled catheter for hemodialysis access was associated with a sevenfold higher odds of death compared with patients using AV fistulas or grafts [
         <a href="#rid16">
          16
         </a>
         ]. Yet, despite these risks and international guidelines favoring early placement of AV fistulas to minimize need for tunneled catheters, the use of tunneled catheters has steadily increased in many countries [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Hemodialysis CRBSIs can lead to metastatic complications such as osteomyelitis, endocarditis, septic arthritis, or epidural abscess. Metastatic infections have been observed in approximately 5 to 10 percent of catheter-dependent hemodialysis patients [
         <a href="#rid18">
          18
         </a>
         ]. The increased frequency of catheter use has led to more frequent metastatic infections [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         The risk of metastatic infection varies with the type of infecting pathogen. As an example, serious metastatic infections are more frequently due to
         <em>
          Staphylococcus aureus
         </em>
         ,
         <em>
         </em>
         which accounts for 10 to 40 percent of such infections [
         <a href="#rid20">
          20,21
         </a>
         ]. In one large series, a metastatic infection occurred in 10 percent of patients with CRBSI caused by
         <em>
          S. aureus
         </em>
         versus 4 percent of patients who had
         <em>
          Staphylococcus epidermidis
         </em>
         or Gram-negative infection [
         <a href="#rid18">
          18
         </a>
         ]. It is important to note that metastatic infections may not be immediately apparent, as they can first manifest clinically weeks or months after the initial bacteremic event.
        </p>
        <p>
         The most important risk factor for tunneled CRBSIs is prolonged use of the catheter [
         <a href="#rid5">
          5,22
         </a>
         ]. Other risk factors include a history of previous CRBSIs, recent surgery, diabetes mellitus, iron overload, immunosuppression, and hypoalbuminemia [
         <a href="#rid4">
          4,23-25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3114236912">
         <span class="h1">
          MICROBIOLOGY AND PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gram-positive organisms are responsible for most hemodialysis catheter-related infections. Coagulase-negative staphylococci and
         <em>
          S. aureus
         </em>
         together account for 40 to 80 percent of cases in most studies [
         <a href="#rid4">
          4,20,26-30
         </a>
         ]. Gram-negative organisms account for 20 to 40 percent, and polymicrobial infections are implicated in 10 to 20 percent of all episodes of catheter-related bloodstream infections (CRBSIs) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         <em>
          S. aureus
         </em>
         infection is commonly associated with significant morbidity and mortality. (See
         <a class="medical medical_review" href="/z/d/html/2135.html" rel="external">
          "Clinical manifestations of Staphylococcus aureus infection in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2139.html" rel="external">
          "Epidemiology of Staphylococcus aureus bacteremia in adults"
         </a>
         .)
        </p>
        <p>
         As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective cohort study of 22,130 hospitalizations of hemodialysis patients with septicemia, the overall death rate from
         <em>
          S. aureus
         </em>
         bacteremia after 12 weeks of follow-up was 34 percent [
         <a href="#rid13">
          13
         </a>
         ]. The death rate was 20 percent higher than the death rate from bacteremia due to all other organisms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In another study, 21 percent of 11,572 admissions of hemodialysis patients for
         <em>
          S. aureus
         </em>
         bacteremia had one or more complications [
         <a href="#rid14">
          14
         </a>
         ]. The average length of first hospitalization was 13 days, and 12 percent of patients needed a readmission to the hospital within 12 weeks for treatment of a relapsed infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, the death rate actually attributable to
         <em>
          S. aureus
         </em>
         bacteremia is lower. As an example, in a series of 84 patients with
         <em>
          S. aureus
         </em>
         bacteremia, only 2 percent had death directly caused by the CRBSI or its metastatic complications [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Methicillin-resistant
         <em>
          S. aureus
         </em>
         (MRSA) infection has also become an important pathogen in this population [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3157.html" rel="external">
          "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology", section on 'Presence of an indwelling hemodialysis catheter'
         </a>
         .)
        </p>
        <p>
         Non-staphylococcal hemodialysis catheter-related bacteremias are predominantly due to enterococci and gram-negative rods [
         <a href="#rid4">
          4,20,26-29,32,33
         </a>
         ]. Human immunodeficiency virus (HIV)-positive hemodialysis patients are more likely to develop polymicrobial infections or infections due to gram-negative or fungal pathogens [
         <a href="#rid34">
          34,35
         </a>
         ].
        </p>
        <p>
         The pathogenesis of hemodialysis CRBSI is similar to that of other catheters. Hemodialysis CRBSIs can arise from one of two sources [
         <a href="#rid4">
          4
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/3806.html" rel="external">
          "Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology", section on 'Sources of infection'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Migration from the skin along the outside of the catheter into the bloodstream. The Dacron cuff in tunneled catheters limits this migration of bacteria by inciting a cascading inflammatory response ending in fibrotic tissue that serves as a mechanical barrier against the skin flora.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Direct inoculation from biofilm-containing pathogenic micro-organisms that may form on the inner surface of the catheter.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H590285411">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although nonspecific, fever and/or chills are the most useful clinical clues to the presence of a catheter-related bloodstream infection (CRBSI). In three prospective clinical studies, the presence of fever or chills in catheter-dependent hemodialysis patients was associated with positive blood cultures in a substantial proportion of patients [
         <a href="#rid33">
          33,36,37
         </a>
         ].
        </p>
        <p>
         Most cases of hemodialysis CRBSIs occur in the absence of an exit-site infection (purulence at the insertion site). However, the presence of an exit-site infection strongly predicts the concurrent presence of a bloodstream infection. In a series of 1436 episodes of tunneled hemodialysis catheter-related bacteremias, a concurrent purulent exit-site infection was observed in only 4.6 percent of cases, including 9.6 percent of those with a
         <em>
          S. epidermidis
         </em>
         infection, 6.1 percent of those with an
         <em>
          S. aureus
         </em>
         infection, and &lt;1 percent of those with a gram-negative infection [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         Less common clinical manifestations of a CRBSI may include hemodynamic instability, altered mental status, catheter dysfunction, and other signs of sepsis, such as hypothermia, acidosis, and hypotension.
        </p>
        <p>
         Complications from CRBSIs, such as suppurative thrombophlebitis, endocarditis, septic arthritis, osteomyelitis, or abscess, may be the first manifestations of infection before a catheter infection becomes apparent. The clinical manifestations of these complications are discussed at length elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7666.html" rel="external">
          "Septic arthritis in adults", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/110529.html" rel="external">
          "Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis", section on 'Skin abscess'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7668.html" rel="external">
          "Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7666.html" rel="external">
          "Septic arthritis in adults", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/110529.html" rel="external">
          "Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis", section on 'Skin abscess'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3781121682">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H4147292500">
         <span class="h2">
          When to suspect a catheter-related bacteremia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Catheter-related blood stream infection (CRBSI) should be suspected in any patient with a hemodialysis catheter and signs and/or symptoms of a systemic infection, particularly when there is no clinical evidence for an alternate source. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
         The diagnostic approach begins with a basic history and physical examination. Indications for additional laboratory and radiologic evaluation depend upon the findings of this evaluation. A CRBSI is confirmed in approximately 85 percent of hemodialysis patients who have a catheter and a suspected infection. Thus, an alternate source of infection is identified in only about 15 percent of such cases [
         <a href="#rid18">
          18,39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1759627972">
         <span class="h2">
          How to confirm diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among patients with a clinical suspicion of CRBSI, a diagnosis is confirmed by two blood cultures obtained
         <strong>
          prior
         </strong>
         to administration of antimicrobial therapy and after exclusion of alternate sources of infection. Blood cultures may be obtained in various combinations from sites including the hemodialysis catheter, hemodialysis circuit, or peripheral veins. Ideally, at least one of the cultures should be obtained from a peripheral vein. However, peripheral vein cultures are infrequently obtained in hemodialysis patients, and hemodialysis circuit cultures are typically drawn instead.
        </p>
        <p>
         A minimum of 10 mL of blood should be obtained from each site. We do not routinely rely on catheter tip culture for diagnosis of CRBSI, as removal of a tunneled catheter at the first suspicion of infection is only indicated in certain circumstances. Patients who have an exit-site infection should have any visible purulent drainage sent for culture.
        </p>
        <p>
         Tests for other potential sources of infection, such as a chest radiograph or urine culture, should be individualized based upon the initial evaluation of the patient (ie, a complete review of systems for symptoms of infection). Among patients with localizing features, appropriate investigations to evaluate the alternate source should be undertaken (eg, chest radiograph for a patient with productive cough). However, among patients with nonspecific systemic symptoms and signs of an infection (eg, fever, chills, malaise) without other localizing features, limiting the evaluation to CRBSI by obtaining blood cultures is usually sufficient.
        </p>
        <p>
         Our choice of the site(s) for blood culture samples depends upon timing of onset of symptoms relative to the timing of the dialysis procedure (see
         <a class="medical medical_review" href="/z/d/html/2133.html" rel="external">
          "Detection of bacteremia: Blood cultures and other diagnostic tests", section on 'Collecting blood cultures'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If a patient develops symptoms shortly before their next hemodialysis session (eg, within a few hours), then we obtain one blood culture sample from the hemodialysis catheter and another one from either a peripheral vein or the hemodialysis circuit bloodline while the patient is on dialysis. Generally, patients present to their next dialysis session with a history of symptom onset in the interdialytic interval.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If a patient develops symptoms or signs of a bloodstream infection during a hemodialysis treatment, then we obtain two samples from the hemodialysis circuit bloodline [
         <a href="#rid40">
          40
         </a>
         ] or one sample from the hemodialysis circuit bloodline and another one from a peripheral vein.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If a patient develops symptoms or signs of a bloodstream infection during the 48- to 72-hour interdialytic interval, but not shortly before their next hemodialysis session (eg, within a few hours), then we obtain one sample from the hemodialysis catheter and another one from a peripheral vein. An alternative is to obtain two samples from peripheral veins. Among patients who are unable to have a peripheral vein sampled, we obtain two samples from the hemodialysis catheter 10 to 15 minutes apart.
        </p>
        <p>
        </p>
        <p>
         Several factors influence the preference by many clinicians for hemodialysis circuit cultures rather than peripheral vein cultures [
         <a href="#rid4">
          4,41-43
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Absence of suitable peripheral veins
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The desire to avoid venipuncture, even if suitable peripheral veins are present, to preserve them for a potential future fistula or graft
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lack of sufficient dialysis nurse proficiency in obtaining peripheral vein cultures, and the absence of phlebotomy teams in the outpatient dialysis setting
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If symptoms occur during a hemodialysis session, it is unlikely that there is a meaningful difference between samples drawn from peripheral veins and those drawn from the hemodialysis tubing while systemic blood is rapidly circulating through the hemodialysis circuit
        </p>
        <p>
        </p>
        <p>
         Thus, among patients who develop symptoms shortly before or during a hemodialysis session, circuit bloodline cultures are a reasonable alternative to peripheral blood cultures in many dialysis patients [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
         The definitive diagnosis of CRBSI requires concurrent blood cultures positive for the same organism from two sites, in the absence of an alternate source of infection. Additional criteria that may be relevant, depending upon the type of organism involved, are presented in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">
          "Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">
          "Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis", section on 'Interpreting blood culture results'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1529840268">
         <span class="h1">
          PREVENTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevention of hemodialysis CRBSI is similar to prevention of other infection due to other central vascular lines. (See
         <a class="medical medical_review" href="/z/d/html/8180.html" rel="external">
          "Central venous catheters: Overview of complications and prevention in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1698434048">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112932.html" rel="external">
          "Society guideline links: Dialysis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2164814253">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology and risk factors
         </strong>
         – The majority of bloodstream infections in patients on hemodialysis are caused by infection of vascular access catheters. The incidence of hemodialysis catheter-related bloodstream infections (CRBSIs) is approximately one to two episodes per catheter-year. Metastatic infections have been observed in approximately 5 to 10 percent of catheter-dependent hemodialysis patients, most frequently in association with
         <em>
          Staphylococcus aureus
         </em>
         infections. (See
         <a class="local">
          'Epidemiology and Risk Factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology and pathogenesis
         </strong>
         – Gram-positive organisms are responsible for most CRBSIs. Coagulase-negative staphylococci and
         <em>
          S. aureus
         </em>
         together account for 40 to 80 percent, gram-negative organisms for 20 to 40 percent, and polymicrobial infections for 10 to 20 percent of all episodes of CRBSIs. The pathogenesis of hemodialysis CRBSI is similar to that of other catheters. It results from migration of bacteria along the outside of the catheter into the bloodstream or by direct inoculation from biofilm-containing pathogenic micro-organisms, which may form on the inner surface of the catheter. (See
         <a class="local">
          'Microbiology and Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Fever and chills are the most useful clinical clues to the presence of CRBSI. Most cases of hemodialysis CRBSIs occur in the absence of a concomitant exit-site infection. Less common clinical manifestations of a CRBSI may include hemodynamic instability, altered mental status, catheter dysfunction, and other signs of sepsis, such as hypothermia, acidosis, and hypotension. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – CRBSI should be suspected in any patient with a hemodialysis catheter and signs and/or symptoms of a systemic infection, particularly when there is no clinical evidence for an alternate source. The diagnosis of CRBSI is confirmed by two blood cultures obtained
         <strong>
          prior
         </strong>
         to administration of antimicrobial therapy and after exclusion of alternate sources of infection. The site of blood culture sampling depends upon timing of onset of symptoms relative to the timing of the dialysis procedure (see
         <a class="local">
          'Diagnosis'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If a patient develops symptoms shortly before their next hemodialysis session (eg, within a few hours), then we obtain one blood culture sample from the hemodialysis catheter and another one from either a peripheral vein or the hemodialysis circuit bloodline while the patient is on dialysis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If a patient develops symptoms or signs of a bloodstream infection during a hemodialysis treatment, then we obtain two samples from the hemodialysis circuit bloodline or one sample from the hemodialysis circuit bloodline and another one from a peripheral vein.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If a patient develops symptoms or signs of a bloodstream infection during the 48- to 72-hour interdialytic interval, but not shortly before their next hemodialysis session (eg, within a few hours), then we obtain one sample from the hemodialysis catheter and another one from a peripheral vein. An alternative is to obtain two samples from peripheral veins. Among patients who are unable to have a peripheral vein sampled, we obtain two samples from the hemodialysis catheter 10 to 15 minutes apart.
        </p>
        <p>
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48 Suppl 1:S2.
          </a>
         </li>
         <li class="breakAll">
          United States Renal Data System. 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 2018.
         </li>
         <li>
          <a class="nounderline abstract_t">
           El Khudari H, Ozen M, Kowalczyk B, et al. Hemodialysis Catheters: Update on Types, Outcomes, Designs and Complications. Semin Intervent Radiol 2022; 39:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 2004; 44:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shingarev R, Barker-Finkel J, Allon M. Natural history of tunneled dialysis catheters placed for hemodialysis initiation. J Vasc Interv Radiol 2013; 24:1289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2002; 39:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weijmer MC, Vervloet MG, ter Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 2004; 19:670.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inrig JK, Reed SD, Szczech LA, et al. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin J Am Soc Nephrol 2006; 1:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fan PY, Schwab SJ. Vascular access: concepts for the 1990s. J Am Soc Nephrol 1992; 3:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor G, Gravel D, Johnston L, et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 2004; 32:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002; 62:620.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allon M, Daugirdas J, Depner TA, et al. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 2006; 47:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Danese MD, Griffiths RI, Dylan M, et al. Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodial Int 2006; 10:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nissenson AR, Dylan ML, Griffiths RI, et al. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis 2005; 46:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allon M, Depner TA, Radeva M, et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol 2003; 14:1863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bray BD, Boyd J, Daly C, et al. Vascular access type and risk of mortality in a national prospective cohort of hemodialysis patients. Q J Med 2012; 105:1097.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rayner HC, Pisoni RL. The increasing use of hemodialysis catheters: evidence from the DOPPS on its significance and ways to reverse it. Semin Dial 2010; 23:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farrington CA, Allon M. Complications of Hemodialysis Catheter Bloodstream Infections: Impact of Infecting Organism. Am J Nephrol 2019; 50:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kovalik EC, Raymond JR, Albers FJ, et al. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol 1996; 7:2264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marr KA, Sexton DJ, Conlon PJ, et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maya ID, Carlton D, Estrada E, Allon M. Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 2007; 50:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee T, Barker J, Allon M. Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. Am J Kidney Dis 2005; 46:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kozeny GA, Venezio FR, Bansal VK, et al. Incidence of subclavian dialysis catheter-related infections. Arch Intern Med 1984; 144:1787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teehan GS, Bahdouch D, Ruthazer R, et al. Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis 2004; 38:1090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanriover B, Carlton D, Saddekni S, et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 2000; 57:2151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999; 10:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheesbrough JS, Finch RG, Burden RP. A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis 1986; 154:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swartz RD, Messana JM, Boyer CJ, et al. Successful use of cuffed central venous hemodialysis catheters inserted percutaneously. J Am Soc Nephrol 1994; 4:1719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Almirall J, Gonzalez J, Rello J, et al. Infection of hemodialysis catheters: incidence and mechanisms. Am J Nephrol 1989; 9:454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobsson G, Dashti S, Wahlberg T, Andersson R. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 2007; 39:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States, 2005. MMWR Morb Mortal Wkly Rep 2007; 56:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dryden MS, Samson A, Ludlam HA, et al. Infective complications associated with the use of the Quinton 'Permcath' for long-term central vascular access in haemodialysis. J Hosp Infect 1991; 19:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 2004; 19:1237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell D, Krishnasami Z, Allon M. Catheter-related bacteraemia in haemodialysis patients with HIV infection. Nephrol Dial Transplant 2006; 21:3185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mokrzycki MH, Schröppel B, von Gersdorff G, et al. Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus. J Am Soc Nephrol 2000; 11:2122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61:1136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vardhan A, Davies J, Daryanani I, et al. Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant 2002; 17:1149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sychev D, Maya ID, Allon M. Clinical management of dialysis catheter-related bacteremia with concurrent exit-site infection. Semin Dial 2011; 24:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Solaiman Y, Estrada E, Allon M. The spectrum of infections in catheter-dependent hemodialysis patients. Clin J Am Soc Nephrol 2011; 6:2247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fabre V, Jones GF, Hsu Y, et al. To wait or not to wait: Optimal time interval between the first and second blood-culture sets to maximize blood-culture yield. Antimicrobial Stewardship &amp; Healthcare Epidemiology 2022; 2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allon M. Treatment guidelines for dialysis catheter-related bacteremia: an update. Am J Kidney Dis 2009; 54:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quittnat Pelletier F, Joarder M, Poutanen SM, Lok CE. Evaluating Approaches for the Diagnosis of Hemodialysis Catheter-Related Bloodstream Infections. Clin J Am Soc Nephrol 2016; 11:847.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 122940 Version 11.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16813990" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Clinical practice guidelines for hemodialysis adequacy, update 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16813990" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Clinical practice guidelines for hemodialysis adequacy, update 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35210738" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Hemodialysis Catheters: Update on Types, Outcomes, Designs and Complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15492943" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Dialysis catheter-related bacteremia: treatment and prophylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23871694" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Natural history of tunneled dialysis catheters placed for hemodialysis initiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11877574" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14767025" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17699254" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1391700" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Vascular access: concepts for the 1990s.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15153927" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12110026" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Vascular access and increased risk of death among hemodialysis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16490626" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Effect of change in vascular access on patient mortality in hemodialysis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16441828" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Mortality differences among organisms causing septicemia in hemodialysis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16112049" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12819247" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Vascular access type and risk of mortality in a national prospective cohort of hemodialysis patients
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20331810" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The increasing use of hemodialysis catheters: evidence from the DOPPS on its significance and ways to reverse it.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31242483" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Complications of Hemodialysis Catheter Bloodstream Infections: Impact of Infecting Organism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8915989" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9265426" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17660030" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16129212" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6476997" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Incidence of subclavian dialysis catheter-related infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15095212" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10792637" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10232691" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Management of bacteremia associated with tunneled-cuffed hemodialysis catheters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3745972" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : A prospective study of the mechanisms of infection associated with hemodialysis catheters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8011982" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Successful use of cuffed central venous hemodialysis catheters inserted percutaneously.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2596535" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Infection of hemodialysis catheters: incidence and mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17366006" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17347644" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States, 2005.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1686038" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Infective complications associated with the use of the Quinton 'Permcath' for long-term central vascular access in haemodialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14993504" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16891646" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Catheter-related bacteraemia in haemodialysis patients with HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11053489" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11849468" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12032220" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Treatment of haemodialysis catheter-related infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21517993" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Clinical management of dialysis catheter-related bacteremia with concurrent exit-site infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21737847" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The spectrum of infections in catheter-dependent hemodialysis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : To wait or not to wait: Optimal time interval between the first and second blood-culture sets to maximize blood-culture yield
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19559337" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Treatment guidelines for dialysis catheter-related bacteremia: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19489710" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27037271" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Evaluating Approaches for the Diagnosis of Hemodialysis Catheter-Related Bloodstream Infections.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
